Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.67 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.66 |
| ▸ | FAAH | O00519 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.53 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7218627 | 1.00 | EPHX2 (0.67) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL9162299 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL17097126 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL1713210 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL8019819 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL25188341 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL15650880 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL872338 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL20552606 | 0.98 | EPHX2 (0.65) | EPHX2NOD1FAAHMEN1MAPK1 | |
| SCHEMBL8005686 | 0.98 | EPHX2 (0.69) | EPHX2NOD1FAAHMEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| EP-4563530-A1 | SPHERICAL CALCIUM CARBONATE PARTICLES | Sakai Chemical Industry Co., Ltd. (JP) | 2025-06-04 | — | — | EP | disclosed |
| CN-119403764-A | Spherical calcium carbonate particles | 堺化学工业株式会社 | 2025-02-07 | — | — | CN | disclosed |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | disclosed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | disclosed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | disclosed |
| WO-2024024651-A1 | SPHERICAL CALCIUM CARBONATE PARTICLES | 堺化学工業株式会社 | 2024-02-01 | — | — | WO | disclosed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023084118-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2023-05-19 | — | — | WO | disclosed |
| EP-4180060-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2023-05-17 | — | — | EP | disclosed |
| CN-109081790-A | The positive positive hexanoyl basic amino acid of hexanoyl amino first cyclic amide base of amino, synthesis, activity and application | 首都医科大学 | 2018-12-25 | — | — | CN | disclosed |
| JP-2003246781-A | METHOD FOR MANUFACTURING OXAZOLE COMPOUND | TAMA KAGAKU KOGYO KK | 2003-09-02 | — | — | JP | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| US-5084523-A | Blends with polyamides and aspartic acid as molding materials with heat resistance and solvent resistance | HUELS AKTIENGESELLSCHAFT (DE) | 1992-01-28 | — | — | US | disclosed |
| EP-0415598-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-03-06 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPPA, BCAT1, ANPEP | EPHX2 4600/4885NOD1 3434/4885FAAH 858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.